Type 2 Diabetes

Manhattan Research, a healthcare market research company, released a survey on Monday announcing the top 10 pharmaceutical product sites visited by physicians.

The American Academy of Pediatrics is now recommending cholesterol-reducing medications for high-risk kids.

This propensity-matched study, in which patients with and without diabetes were well balanced in all measured baseline characteristics, including traditional risk factors and comorbidities, found that diabetes was associated with increased mortality and hospitalization in ambulatory patients who had chronic, mild-to-moderate heart failure and were receiving angiotensin-converting enzyme inhibitors. These findings also highlight the sex- and age-related variations in the effect of diabetes in these patients.

A recent meta-analysis of 31 randomized controlled trials with 4500 participants showed that metformin treatment significantly decreased weight, improved dyslipidemia and insulin resistance, and reduced the incidence of new-onset diabetes by 40%, with beneficial effects maintained over time. Further studies will show whether the metabolic improvements achieved with metformin treatment will ultimately result in a decrease in cardiovascular morbidity and mortality.

Cardiovascular disease accounts for 65 percent of patient deaths among people with type 2 diabetes.

Hemodialysis has evolved over the last 50 years as a life-saving treatment for people with renal failure. Now, there is a new treatment.

What has changed in diabetes medicine over the years? In this ongoing series exploring "Old Tyme Medicine," Bradley Schmidt takes a look at treating diabetes -- then, now, tomorrow, and beyond.